Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04607135 · ClinicalTrials.gov registry record · NA
ARFI Imaging for Targeted Prostate Biopsy
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT04607135 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 34 participants.
The verdict
NCT04607135, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate a new ultrasound technique. This technique may provide additional and improved information about the stiffness and sizes of the internal structures of your prostate in order to improve the guidance for a targeted biopsy. The investigational, custom-designed probe and needle guide will be used to produce images of your prostate and provide guidance for up to 4 additional biopsy samples (cores) prior to a standard magnetic resonance (MR) ultrasound fusion biopsy procedure. Above the time required for the MR ultrasound fusion biopsy, this study will take up to 30 additional minutes of time for collection of the investigational device guided collection of biopsy samples Risks of participation include increased time under anesthesia (to collect additional biopsies) and slight heating of tissue.
Interventions
- DEVICE Ultrasound
- DEVICE Acoustic radiation force impulse (ARFI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2021-10-22 |
| Est. Completion | 2023-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04607135
The ClinicalTrials.gov registry entry for NCT04607135 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ultrasound is the first listed.
NCT04607135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04607135 about?
NCT04607135 is a clinical study titled "ARFI Imaging for Targeted Prostate Biopsy". The purpose of this study is to evaluate a new ultrasound technique. This technique may provide additional and improved information about the stiffness and sizes of the internal structures of your prostate in order to improve the guidance for a targeted biopsy. The investigational, custom-designed p...
What is the current status of trial NCT04607135?
This trial is currently terminated. It is a NA study. The enrollment target is 34 participants. The study started on 2021-10-22. Estimated completion is 2023-03-28.
What interventions are being tested in trial NCT04607135?
The interventions under investigation include: Ultrasound (DEVICE), Acoustic radiation force impulse (ARFI) (DEVICE).
Who is sponsoring clinical trial NCT04607135?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.